ARCHIVES

FDA Approves BMS’s Yervoy For Metastatic Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Concepts For New CTEP, RRP Grants

February 24, 1989

Senate Calls Cancer Research a Priority, Cites Research Task Force Funding Goal

October 8, 1999

NCCN Also to Warn Doctors. Amgen’s Pledges to Disclose Future Results.

February 23, 2007

Senate Gives NIH Director Authority To Permit Research By Unconventional MDs

September 25, 1992

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

December 10, 2004

Reinventing NCI: Prevention Program Lacks Leadership, Reorganization Needed, Advisory Group Says

June 20, 1997